208 related articles for article (PubMed ID: 11642691)
1. Fluoroquinolone adverse effects and drug interactions.
Fish DN
Pharmacotherapy; 2001 Oct; 21(10 Pt 2):253S-272S. PubMed ID: 11642691
[TBL] [Abstract][Full Text] [Related]
2. The fluoroquinolones.
Walker RC
Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871
[TBL] [Abstract][Full Text] [Related]
3. The safety profile of the fluoroquinolones.
Bertino J; Fish D
Clin Ther; 2000 Jul; 22(7):798-817; discussion 797. PubMed ID: 10945507
[TBL] [Abstract][Full Text] [Related]
4. Overview of the fluoroquinolone antibiotics.
Just PM
Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
[TBL] [Abstract][Full Text] [Related]
5. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
6. New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safety.
Rodvold KA; Piscitelli SC
Clin Infect Dis; 1993 Aug; 17 Suppl 1():S192-9. PubMed ID: 8399914
[TBL] [Abstract][Full Text] [Related]
7. Levofloxacin and sparfloxacin: new quinolone antibiotics.
Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
[TBL] [Abstract][Full Text] [Related]
8. New classification and update on the quinolone antibiotics.
King DE; Malone R; Lilley SH
Am Fam Physician; 2000 May; 61(9):2741-8. PubMed ID: 10821154
[TBL] [Abstract][Full Text] [Related]
9. Safety of the new fluoroquinolones compared with ciprofloxacin.
Ball P
J Chemother; 2000 Jan; 12 Suppl 1():8-11. PubMed ID: 11414383
[TBL] [Abstract][Full Text] [Related]
10. A critical review of the fluoroquinolones: focus on respiratory infections.
Zhanel GG; Ennis K; Vercaigne L; Walkty A; Gin AS; Embil J; Smith H; Hoban DJ
Drugs; 2002; 62(1):13-59. PubMed ID: 11790155
[TBL] [Abstract][Full Text] [Related]
11. Levofloxacin and trovafloxacin: the next generation of fluoroquinolones?
Ernst ME; Ernst EJ; Klepser ME
Am J Health Syst Pharm; 1997 Nov; 54(22):2569-84. PubMed ID: 9397218
[TBL] [Abstract][Full Text] [Related]
12. Microbiologic aspects of fluoroquinolones.
Neu HC
Am J Ophthalmol; 1991 Oct; 112(4 Suppl):15S-24S. PubMed ID: 1928268
[TBL] [Abstract][Full Text] [Related]
13. Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99).
Jones RN; Pfaller MA;
Diagn Microbiol Infect Dis; 2001 Apr; 39(4):237-43. PubMed ID: 11404067
[TBL] [Abstract][Full Text] [Related]
14. [In vitro evaluation of lomefloxacin].
Dette GA; Knothe H
Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates.
Tanaka M; Tunoe H; Mochida O; Kanayama A; Saika T; Kobayashi I; Naito S
Diagn Microbiol Infect Dis; 2000 Oct; 38(2):109-13. PubMed ID: 11035242
[TBL] [Abstract][Full Text] [Related]
16. Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.
Clark DW; Layton D; Wilton LV; Pearce GL; Shakir SA
Drug Saf; 2001; 24(15):1143-54. PubMed ID: 11772147
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.
Paton JH; Reeves DS
Drugs; 1988 Aug; 36(2):193-228. PubMed ID: 3053126
[TBL] [Abstract][Full Text] [Related]
18. Quinolone toxicity: methods of assessment.
Patterson DR
Am J Med; 1991 Dec; 91(6A):35S-37S. PubMed ID: 1767805
[TBL] [Abstract][Full Text] [Related]
19. Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin).
Cormican MG; Marshall SA; Jones RN
Diagn Microbiol Infect Dis; 1995 Jan; 21(1):51-4. PubMed ID: 7789097
[TBL] [Abstract][Full Text] [Related]
20. The role of the fluoroquinolones.
Guay DR
Pharmacotherapy; 1992; 12(6 Pt 2):71S-85S. PubMed ID: 1480503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
